| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c76ecadad74a1a35270b3e3a34d60f37 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08 |
| filingDate |
2002-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35c4df8dc818c59d4a382dad3b0c2cfa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_900e00b2a0252d79d5c2653dcd711e28 |
| publicationDate |
2006-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1652851-A1 |
| titleOfInvention |
New crystal form of Azithromycin |
| abstract |
The present invention relates to novel crystalline forms of azithromycin, an antibiotic useful in the treatment of infections. In particular, the invention relates to a crystalline form of azithromycin, wherein said form is substantially pure crystalline azithromycin monohydrate hemi-ethanol solvate. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011073927-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102712670-A |
| priorityDate |
2001-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |